Correlation Between GeneFerm Biotechnology and Acer E

Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and Acer E at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and Acer E into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneFerm Biotechnology Co and Acer E Enabling Service, you can compare the effects of market volatilities on GeneFerm Biotechnology and Acer E and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of Acer E. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and Acer E.

Diversification Opportunities for GeneFerm Biotechnology and Acer E

0.36

Correlation Coefficient

GeneFerm Biotechnology  Acer E

Weak diversification

The 3 months correlation between GeneFerm and Acer is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and Acer E Enabling Service in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer E Enabling and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with Acer E. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer E Enabling has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and Acer E go up and down completely randomly.

Pair Corralation between GeneFerm Biotechnology and Acer E

Assuming the 90 days trading horizon GeneFerm Biotechnology Co is expected to under-perform the Acer E. But the stock apears to be less risky and, when comparing its historical volatility, GeneFerm Biotechnology Co is 1.34 times less risky than Acer E. The stock trades about -0.08 of its potential returns per unit of risk. The Acer E Enabling Service is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  26,349  in Acer E Enabling Service on September 5, 2024 and sell it today you would lose (1,999) from holding Acer E Enabling Service or give up 7.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

GeneFerm Biotechnology Co  vs.  Acer E Enabling Service

GeneFerm Biotechnology

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Acer E Enabling

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Acer E Enabling Service are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Acer E is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with GeneFerm Biotechnology and Acer E

The main advantage of trading using opposite GeneFerm Biotechnology and Acer E positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, Acer E can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer E will offset losses from the drop in Acer E's long position.

The idea behind GeneFerm Biotechnology Co and Acer E Enabling Service pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.